Abstract

Virtual screening is a computational strategy used in drug discovery research to identify active small molecules against a certain biological target from a large chemical library. It typically consists of a cascade of steps to narrow down a set of hits with potential biological activities from a large small-molecule library. Virtual screening methods can be divided into two broad categories: (1) structure-based virtual screening (SBVS) and (2) ligand-based virtual screening (LBVS). SBVS methods utilize target structure information to identify molecules that fit into the binding site of the target structure. It is also named docking-based virtual screening because it uses molecular docking as the core technology. LBVS methods utilize a set of active ligands to identify similar compounds based on certain measurements. In contrast, the LBVS methods directly search a small-molecule library with a set of molecules that known activities. According to the molecular representation, the LBVS methods can be grouped as two–dimensional (2D) fingerprint similarity searching pharmacophore matching and three-dimensional (3D) shape screening. In this work, we introduced the methodology and implementations of both SBVS and LBVS and small-molecular libraries that are widely used in the field, as well as the issues and challenges facing the virtual screening campaigns.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call